Samad Tarek
Principal Investigator
Neurology
Pfizer
Poland
Biography
Samad Tarek, PhD, is a Pfizer Investigator and the Head of the Neuroinflammation Research Group at Pfizer’s Neuroscience Research Unit. Dr. Samad received his Master’s and PhD degrees in molecular and cellular neurobiology with a focus on dopaminergic pathways in neurodegenerative diseases, from Louis Pasteur University in Strasbourg, France. He also holds a Master’s degree in Genetic Engineering. He joined Massachusetts General Hospital and Harvard Medical School and became a faculty.
Research Interest
Samad Tarek has broad interests in the novel molecular and cellular mechanisms of neuroimmune modulation and their contribution to brain pathologies, Bone Morphogenetic Protein signaling in the nervous system and identified a novel family of Bone Morphogenetic Protein co-receptors with members modulating neuronal regeneration after nerve injury, and iron homeostasis and emerging scientific concepts, and identifies and validates therapeutic targets for innovative medicines in neurological and neurodegenerative disorders.
